Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Vaccine
Authors: Timo Vesikari, Thomas Becker, Vincent Gajdos, Anne Fiquet, Stéphane Thomas, Patrick Richard, Martine Baudin
Language: English
Topic: Virology and Viral Diseases
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Merck, World Health Organization
OpenAlex ID: W2000206730